Neurotrophins - More than neurotrophic

Current Immunology Reviews

Volumn 3, Issue 3, 2007, Pages 189-215

  Ayyadhury, Shamini ^a   Heese, Klaus ^b  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Allergy; B cell; Inflammation; Nephropathy; Nerve growth factor

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; OXIDOPAMINE; RECOMBINANT NERVE GROWTH FACTOR; RECOMBINANT NEUROTROPHIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC ASTHMA; ALZHEIMER DISEASE; B LYMPHOCYTE ACTIVATION; BLOOD BRAIN BARRIER; BONE MARROW; BRAIN BLOOD FLOW; CELL INFILTRATION; CELL MATURATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DIABETIC NEPHROPATHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; DRUG MECHANISM; GENE THERAPY; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; LEUKOCYTE; LYMPH NODE; MEMORY CELL; MENINX; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NERVOUS SYSTEM INFLAMMATION; NEUROANATOMY; NONHUMAN; PAIN; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SPINAL CORD BLOOD FLOW; THYMUS FUNCTION; VERTEBRATE;

EID: 41649104921     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339507781483504     Document Type: Review

References (268)

1. Man S, Ubogu EE, Ransohoff RM. Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol 2007; 17: 243-50.
2. Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003; 9: 540-9.
3. Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H. Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol Sci 2006; 27: S1-7.
4. Correale J, Villa A. The neuroprotective role of inflammation in nervous system injuries. J Neurol 2004; 251: 1304-16.
5. Hennigan A, O'callaghan RM, Kelly AM. Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. Biochem, Soc Trans 2007; 35: 424-7.
6. Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005; 26: 485-95.
7. Squire LR, Bloom FE, McConnell SK, Roberts JL, Spitzer NC, Zigmond MJ, eds. Fundamental Neuroscience, Academic Press, 2nd edition, 2002:29-44.
8. Haines DE, ed. Fundamental Neuroscience, Churchill Livingstone, 2nd edition, 2001: 4-14.
9. Crossman AR, Neary D, eds. Neuroanatomy, Churchill Livingstone, 3rd edition, 2005: 59-65.
10. Haines DE, eds. Neuroanatomy, Lippincott Williams & Wilkins, 6th edition, 2004: 239-52.
11. Weller RO. Microscopic morphology and histology of the human meninges. Morphologie 2005; 89: 22-34.
12. Vandenabeele F, Creemers J, Lambrichts I. Ultrastructure of the human spinal arachnoid mater and dura mater. J Anat 1996; 189: 417-30.
13. Zhang J, Goodlett DR, Montine TJ. Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. J Alzheimers Dis 2005; 8: 377-86.
14. Formichi P, Battisti C, Radi E, Federico A. Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease. J Cell Physiol 2006; 208: 39-46.
15. Hickey WF. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001; 36: 118-24.
16. Bailey SL, Carpentier PA, McMahon EJ, Begolka WS, Miller SD. Innate and adaptive immune responses of the central nervous system, Crit Rev Immunol 2006; 26: 149-88
17. Engelhardt B. Regulation of immune cell entry into the central nervous system. Results Probl. Cell Differ 2006; 43: 259-80.
18. Moody DM. The blood-brain barrier and blood-cerebral spinal fluid barrier Semin. Cardiothorac. Vasc Anesth 2006; 10: 128-31.
19. Engelhardt B, Wolburg-Buchholz K, Welburg H. Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech 2001; 52: 112-29.
20. Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the Beta2 Integrin LFA-1 involved in transendothelial migration of leukocytes. Nature Immunol 2002; 3: 151-8.
21. Vezzani A, Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46: 1724-43.
22. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006; 12: 1005-15.
23. McGeer PL, McGeer EG. Inflammation and the degenerative diseases of aging. Ann NY Acad Sci 2004; 1035: 104-16.
24. Schwartz M, Kipnis J. Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk'. Trends Immunol 2002; 23: 510-4.
25. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav Immun 2003; 17: 13-9.
26. Gregory GD, Robbie-Ryan M, Secor VH, Sabatino-JJ Jr, Brown MA. Mast cells are required for optimal autoreactive T cell responses in a marine model of multiple sclerosis. Eur J Immunol 2005; 35: 3478-86.
27. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147: S232-40.
28. Walker PR, Calzascia T, de Tribolet N, Dietrich PY. T-cell. immune responses in the brain and their relevance for cerebral malignancies. Brain Res Brain Res Rev 2003; 42: 97-122.
29. Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006; 29: 507-38.
30. Chaturvedi RK, Shukla S, Seth K, Agrawil AK. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Neurosci Lett 2006; 398: 44-9.
31. Heese Y, Akatsu H. Alzheimer's disease - an interactive perspective. Curr Alzheimer Res 2006; 3: 109-21.
32. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003; 43: 545-84.
33. Huang EJ, Reichard LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Neurosci 2003; 72: 609-42.
34. Huang EJ, Reichard LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736.
35. Dechant G, Neumann H. Neurotrophins. Adv Exp Med Biol 2002; 513: 303-34.
36. Heese K, Low JW, Inoue N. Nerve growth factor, neural stem cells and Alzheimer's disease. Neurosignals 2006-2007; 15: 1-12.
37. Heese K, Yamada T, Nagai Y, Sawada T. New aspects about APP signalling. Brain Aging 2003; 3: 15-20.
38. Heese K, Inoue, N, Nagai Y, Sawada T. APP, NGF & the Sunday-driver' in a trolley on the road. Rest Neurol Neurosci 2004; 22: 131-6.
39. Blasko I, Lederer W, Oberbauer H, et al. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord 2006; 21: 9-15.
40. Mashayekhi F, Salehin Z. Cerebrospinal fluid nerve growth factor levels in patients with Alzheimer's disease. Ann Saudi Med 2006; 26: 278-82.
41. Lewin GR, Barde YA. Physiology of Neurotrophins. Annu Rev Neurosci 1996; 19:289-317.
42. Collins F, Dawson A. An effect of nerve growth factor on parasympathetic neurite outgrowth. Proc Natl Acad Sci USA 1983; 80: 2091-4.
43. Johnson EM Jr, Yip HK. Central nervous system and peripheral nerve growth factor provide trophic support critical to mature sensory neuronal survival. Nature 1985; 314: 751-2.
44. Edgar D, Barde YA, Thoenen H. Subpopulations of cultured chick sympathetic neurons differ in their requirements for survival factors. Nature 1981; 289: 294-5.
45. Elmariah SB, Hughes EG, Oh EJ, Balice-Gordon RJ. Neurotrophin signaling among neurons and glia during formation of tripartite synapses. Neuron Glia Biol 2005; 1: 1-11.
46. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 2003; 4: 299-309.
47. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1545-64.
48. Schweigreiter R. The dual nature of neurotrophins. Bioassays 2006; 28: 583-94.
49. Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005; 6: 603-14.
50. Mendell LM, Albers KM, Davis BM. Neurotrophins, nociceptors, and pain. Microsc Res Tech 1999; 45: 252-61.
51. Kuipers SD, Bramham CR. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 2006; 9: 580-6.
52. Sendwer M, Holtmann B, Hughes RA. The response of motoneurons to neurotrophins. Neurochem Res 1996; 21: 831-41.
53. Pitts EV, Potluri S, Hess DM, Balice-Gordon RJ. Neurotrophin and Trk-mediated signaling in the neuromuscular system. Int Anesthesiol Clin 2006; 44: 21-76.
54. Johnson JE, Barde YA, Schwab M, Thoenen H. Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells. J Neurosci 1986; 6: 3031-8.
55. Davies AM, Thoenen H, Barde YA. The response of chick sensory neurons to brain-derived neurotrophic factor. J Neurosci 1986; 6: 1897-1904.
56. Chao MV, Rajagopal R, Lee FS. Neurotrophin signalling in health and disease. Clin Sci 2006; 110: 167-73.
57. Agassandian K, Gedney M, Cassell MD. Neurotrophic factors in the central nucleus of amygdala may be organized to provide substrates for associative learning. Brain Res 2006; 1076: 78-86.
58. McTigue DM, Horner PJ, Stokes BT, Gage FH. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 1998; 18: 5354-65.
59. Sawai H, Clarke DB, Kittlerova P, Bray GM, Aguayo AJ. Brain-derived neurotrophic factor and neurotrophin-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells. J Neurosci 1996; 16: 3887-94.
60. Kobayashi NR, Fan DP, Giehl KM, Bedard AM, Wiegand SJ. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci 1997; 17: 9583-95.
61. Clarke DB, Bray GM, Aguayo AJ. Prolonged administration of NT-4/5 fails to rescue most axotomized retinal ganglion cells in adult rats. Vision Res 1998; 38: 1517-24.
62. Narhi LO, Rosenfeld R, Talvenheimo J, et al. Comparison of the biophysical characteristics of human brain-derived neurotrophic factor, neurotrophin-3, and nerve growth factor. J Biol Chem 1993; 268: 13309-17.
63. Wehrman T, He X, Raab B, Dukipatti A, Blau H, Garcia KC. Structural and mechanistic insights into nerve growth factor interactions with the trkA and p75 receptors. Neuron 2007; 53: 25-38.
64. He XL, Garcia KC. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 2004; 304: 870-5.
65. Nykjaer A, Lee R, Teng KK, et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427: 843-8.
66. Nykjaer A, Willnow TE, Petersen CM. p75NTR-live or let die. Curr Opin Neurobiol 2005; 15: 49-57.
67. Barker PA. p75NTR is positively promiscuous: novel partners and new insights. Neuron 2004; 42: 529-33.
68. Hempstead BL. Dissecting the diverse actions of pro- and mature neurotrophins. Curr Alzheimer Res 2006; 3: 19-24.
69. Barker PA, Hussain NK, McPherson PS. Retrograde signaling by the neurotrophins follows a well-worn trk. Trends Neurosci 2002; 25: 379-81.
70. Campenot RB, MacInnis BL. Retrograde transport of neurotrophins: fact and function. J Neurobiol 2004; 58: 217-29.
71. von Bartheld CS, Wang X, Butowt R. Anterograde axonal transport, transcytosis, and recycling of neurotrophic factors: the concept of trophic currencies in neural networks. Mol Neurobiol 2001; 24: 1-28.
72. Caleo, M, Cenni MC. Anterograde transport of neurotrophic factors: possible therapeutic implications. Mol Neurobiol 2004; 29: 179-96.
73. Miller FD, Kaplan DR. Neurobiology. TRK makes the retrograde. Science 2002; 295: 1471-3.
74. Reichardt LF, Mobley WC. Going the distance, or not, with neurotrophin signals. Cell 2004; 118: 141-3.
75. Schinder AF, Poo M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci 2000, 23: 639-45.
76. Lim KC, Lim ST, Federoff HJ. Neurotrophin secretory pathways and synaptic plasticity. Neurobiol Aging 2003; 24: 1135-45.
77. Lessmann V, Gottmann K, Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog Neurobiol 2003; 69: 341-74.
78. Lu B. Pro-region of neurotrophins: role in synaptic modulation. Neuron 2003; 59: 735-8.
79. Castren E, Tanila H. Neurotrophins and dementia-keeping in touch. Neuron 2006; 51: 1-3.
80. Salehi A, Delcroix JD, Belichenko PV, et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes chotinergic neuron degeneration. Neuron 2006; 51: 29-42.
81. Dorsey SG, Renn CL, Carim-Todd L, et al. In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron 2006; 51: 21-8.
82. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000; 10: 381-91.
83. Biswas SC, Greene LA. Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phosphorylation. J Biol Chem 2002; 277: 49511-6.
84. Taglialatela. G, Robinson R, Perez-Polo JR. Inhibition of nuclear factor kappa B (NFkappaB) activity induces nerve growth factor-resistant apoptosis in PC12 cells. J Neurosci Res 1997; 47: 155-62.
85. Arthur DB, Akassoglou K, Insel PA. P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci USA 2005; 102: 19138-43.
86. Moughal NA, Waters C, Sambi B, Pyne S, Pyne NJ. Nerve growth factor signaling involves interaction between the Trk A receptor and lysophosphatidate receptor 1 systems: nuclear translocation of the lysophosphatidate receptor 1 and Trk A receptors in pheochromocytoma 12 cells. Cell Signal 2004; 16: 127-36.
87. Rakhit S, Pyne. S, Pyne NJ. Nerve growth factor, stimulation of p42/p44 mitogen-activated protein kinase in PC12 cells: role of G(i/o), G protein-coupled receptor kinase 2, beta-arrestin I, and endocytic processing. Mol Pharmacol 2001; 60: 63-70.
88. Miller MW, Pitts FA. Neurotrophin receptors in the somatosensory cortex of the mature rat: co-localization of p75, trk, isoforms and c-neu. Brain Res 2000; 852: 355-66.
89. Vaskovsky A, Lupowitz Z, Erlich S, Pinkas-Kramarski R. ErbB-4 activation promotes neurite outgrowth in PC12 cells. J Neurochem 2000; 74: 979-87.
90. Ricart K, J Pearson R Jr, Viera L, et al. Interactions between beta-neuregulin and neurotrophins in motor neuron apoptosis. J Neurochem 2006; 97: 222-33.
91. Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science 2001; 294: 1945-8.
92. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 2005; 435: 590-7.
93. Cumano A, Godin I. Ontogeny of the Hematopoietic System. Annu Rev Immunol 2007; 25: 745-85.
94. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006; 211: 609-18.
95. Krysko DV, D'Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006; 11: 1709-26.
96. Castellano G, Woltman AM, Schena FP, Roos A, Daha MR, van Kooten C. Dendritic cells and complement: at the cross road of innate and adaptive immunity. Mol Immunol 2004; 41: 133-40.
97. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006; 311: 17-58.
98. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
99. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol 2006; 315: 13-34.
100. Marshall JS, Jawdat DM. Mast cells in innate immunity. J Allergy Clin Immunol 2004; 114: 21-7.
101. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 135-42.
102. Kato T, Kitagawa S. Regulation of neutrophil fitrictions by proinflammatory cytokines. Int J Hematol 2006; 84: 205-9.
103. Appelberg R. Neutrophils and intracellular pathogens: beyond phagocytosis and killing. Trends Microbiol 2007; 15: 87-92.
104. Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004; 113: 30-7.
105. Min B, Le Gros G, Paul WE. Basophils: a potential liaison between innate and adaptive immunity. Allergol Int 2006; 55: 99-104.
106. Falcone FH, Zillikens D, Gibbs BF. The 21st century renaissance of the basophil? Current insights into its role in allergic responses and innate immunity. Exp Dermatol 2006; 15: 855-64.
107. Chaplin DD. 1. Overview of the human immune response. J Allergy Clin Immunol 2006; 117: S430-5.
108. Clark R, Kupper T. Old meets new: the interaction between innate and adaptive immunity. J Invest Dermatol 2005; 125: 629-37.
109. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006; 7: 507-16.
110. Castellino F, Germain RN. Cooperation between CD4+ and CD8+ T cells: when, where, and how. Annu Rev Immunol 2006; 24: 519-40.
111. McHeyzer-Williams MG, McHeyzer-Williams LJ, Malherbe L. B cells discriminate the rules of engagement. Immunity 2006; 24: 125-7.
112. Fu YX, Chaplin DD. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 1999; 17: 399-433.
113. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol. 2004; 5: 981-6.
114. Medzhitov R, Janeway,C Jr. Innate immunity. N Engl J Med 2000; 343: 338-44.
115. Roozendaal R, Carroll MC. Emerging patterns in complement-mediated pathogen recognition. Cell 2006; 125: 29-32.
116. Helmy KY, Katschke KJ Jr, Gorgani NN, et al. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 2006; 124: 915-27.
117. Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cell Immunol 2005; 238: 1-9.
118. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-80.
119. Natarajan K, Dimasi N, Wang J, Mariuzza RA, Margulies, DH. Structure and furiction of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002; 20: 853-85.
120. MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-50.
121. Garcia KC, Adams EJ. How the T cell receptor sees antigen--a structural view. Cell 2005; 122: 333-6.
122. Nossal GJ. The double helix and immunology. Nature 2003; 421: 440-4.
123. Carroll MC. The role of complement in B cell activation and tolerance. Adv Immunol 2000; 74: 61-88.
124. Bromley SYC, Burack WR, Johnson KG, et al. The immunological synapse. Annu Rev Immunol 2001; 19: 375-96.
125. Labouyrie E, Dubus P, Groppi A, et al. Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol 1999; 154: 405-15.
126. Chevalier S, Praloran V, Smith C, et al. Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells. Blood 1994; 83: 1479-85.
127. Lomen-Hoerth C, Shooter EM. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J Neurochem 1995; 64: 1780-9.
128. Caneva L, Soligo D, Cattoretti G, De Harven E, Deliliers GL. Immuno-electron microscopy characterization of human bone marrow stromal cells with anti-NGFR antibodies. Blood Cells Mol Dis 1995; 21: 73-85.
129. Levi-Montalcini R. The saga of the nerve growth factor. Neuroreport 1998; 9: R71-83.
130. Simone MD, De Santis S, Vigneti E. Papa G, Amadori S, Aloe L. Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol Oncol 1999; 17: 1-10.
131. Leon A, Buriani A, Dal Toso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91: 3739-43.
132. Tsuda T, Wong D, Dolovich J, Bienenstock J, Marshall J, Denburg JA. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood 1991; 77: 971-9.
133. Matsuda H, Kannan Y, Ushio H, et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991; 174: 7-14.
134. Chevalier S, Praloran V, Smith C, et al. Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells. Blood 1994; 83: 1479-85.
135. Bracci-Laudiero L, Celestino D, Starace G, et al. CD34-positive cells in human umbilical cord blood express nerve growth factor and its specific receptor TrkA. J Neuroimmunol 2003; 136: 130-9.
136. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996; 19: 514-20.
137. Bonini S, Rasi G, Bracci-Laudiero ML, Procoli A, Aloe L. Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol 2003; 131: 804.
138. Timmusk D, Belluardo N, Metsis M, Persson H. Widespread and developmentally regulated expression of neurotrophin-4 mRNA in rat brain and peripheral tissues. Eur J Neurosci 1993; 5: 605-13.
139. Schulte-Herbruggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A. Tumor necrosis factor-alpha aid interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 2005; 160: 204-9.
140. Moalem G, Gdalyahu A, Shani Y, et al. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 2000; 15: 331-45.
141. Matsuda, H, Coughlin MD, Bienenstock J, Denburg JA. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA 1988; 85: 6508-12.
142. Scully JL, Otten U. NGF: Not Just for Neurons. Cell Biol Int 1995; 19: 459-69.
143. Schuhmann B, Dietrich A, Sel S, et al. A role for brain-derived neurotrophic factor in B cell development. J Neuroimmunol 2005; 163: 15-23.
144. Wang LC, Swat W, Fujiwara Y, et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev 1998; 12: 2392-402.
145. Cashman JD, Lapidot T, Wang JC, et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 1997; 89: 4307-16.
146. Verfaillie CM. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 1992; 79: 2821-6.
147. Katoh-Semba R, Kaisho Y, Shintani A, Nagahama M, Kato K. Tissue distribution and immunocytochemical localization of neurotrophin-3 in the brain and peripheral tissues of rats. J Neurochem 1996; 66: 330-7.
148. Bianco P, Gehron Robey P. Marrow stromal stem cells. J Clin Invest 2000; 105: 1663-8.
149. Cancedda R, Bianchi G, Derubeis A, Quarto R. Cell therapy for bone disease: a review of current status. Stem Cells 2003; 21: 610-9.
150. Hall BM, Gibson LF. Regulation of lymphoid and myeloid leukemic cell survival: role of stromal cell adhesion molecules. Leuk Lymphoma 2004; 45: 35-48.
151. Mizel SB. The interleukins. FASEB J 1989; 3: 2379-88.
152. Nagasawa. T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 2006; 6: 107-16.
153. Arai F, Hirao A, Suda T. Regulation of hematopoietic stem cells by the niche. Trends Cardiovasc Med 2005; 15: 75-9.
154. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001; 97: 3075-85.
155. Labouyrie E, Dubus P, Groppi A, et al. Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol 1999; 154: 405-15.
156. Li Y, Chen J, Chen XG, et al. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 2002; 59: 514-23.
157. Lu P, Jones LL, Tuszynski MH. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp Neurol 2005; 191: 344-60.
158. Chen Q, Long Y, Yuan X, et al. Protective effects of bone marrow stromal cell transplantation in injured rodent brain: synthesis of neurotrophic factors. J Neurosci Res 2005; 80: 611-9.
159. Hattori K, Heissig B, Wu Y, et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 2002; 8: 841-9.
160. Yarden Y, Kuang WJ, Yang-Feng T, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6: 3341-51.
161. Kannan Y, Matsuda H, Ushio H, Kawamoto K, Shimada Y. Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor. Int Arch Allergy Immunol 1993; 102: 362-7.
162. Tsuda T, Wong D, Dolovich J, Bienenstock J, Marshall J, Denburg JA. Synergistic effects of nerve growth factor and granulocyte-macrophage colony-stimulating factor on human basophilic cell differentiation. Blood 1991; 77: 971-9.
163. Larsson J, Karlsson S. The role of Smad signaling in hematopoiesis. Oncogene 2005; 24: 5676-92.
164. Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004; 28: 509-54.
165. Mufson RA. The role of serine/threonine phosphorylation in hematopoietic cytokine receptor signal transduction. FASEB J 1997; 11: 37-44.
166. Auffray I, Chevalier S, Froger J, et al. Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7. Blood 1996; 88: 1608-18.
167. Greene LA, Angelastro JM. You can't go home again: transcriptionally driven alteration of cell signaling by NGF. Neurochem Res 2005; 30: 1347-52.
168. Khwaja A. The rolef of Janus kinases in haemopoiesis and haematological malignancy. Br J Haematol 2006; 134: 366-84.
169. Thomas D, Vadas M, Lopez A. Regulation of haematopoiesis by growth factors - emerging insights and therapies. Expert Opin Biol Ther 2004; 4: 869-79.
170. Scheele JS, Ripple D, Lubbert M. The role of ras and other low molecular weight guanine nucleotide (GTP)-binding proteins during hematopoietic cell differentiation. Cell Mol Life Sci 2000; 57: 1950-63.
171. Katayama N, Nishikawa M, Komada F, Minami N, Shirakawa S. A role for calmodulin in the growth of human hematopoietic progenitor cells. Blood 1990; 75: 1446-54.
172. Gotz R. Regulation of neuronal cell death and differentiation by NGF and IAP family members. J Neural Transm Suppl 2000; 60: 247-59.
173. Massa SM, Xie Y, Yang T, et al. Small nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death. J Neurosci 2006; 26: 5288-5300.
174. Burgi B, Otten UH, Ochensberger B, et al. Basophil priming by neurotrophic factors. Activation through the trk receptor. J Immunol 1996; 157: 5582-8.
175. Miura K, Saini SS, Gauvreau G, MacGlashan DW Jr. Differences in functional consequences and signal transduction induced by IL-3, IL-5, and nerve growth factor in human basophils. J Immunol 2001; 167: 2282-91.
176. Levi-Montalcini R, Dal Toso R, della Valle F, Skaper SD, Leon A. Update of the NGF saga. J Neurol Sci 1995; 130: 119-27.
177. Otten U, Marz P, Heese K, Hock C, Kunz D, Rose-John S. Cytokines and neurotrophins interact in normal and diseased states. Ann NY Acad Sci 2000; 917: 322-30.
178. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989; 86: 10059-63.
179. Torcia M, Bracci-Laudiero L, Lucibello M, et al. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 1996; 85: 345-56.
180. Brodie C, Gelfand EW. Regulation of immunoglobulin production by nerve growth factor: comparison with anti-CD40. J Neuroimmunol. 1994; 52: 87-96.
181. Brodie C, Oshiba A, Renz H, Bradley K, Gelfand EW. Nerve growth-factor and anti-CD40 provide opposite signals for the production of IgE in interleukin-4-treated lymphocytes. Eur J Immunol 1996; 26: 171-8.
182. Coppola V, Barrick CA, Southon EA. et al. Ablation of TrkA function in the immune system causes B cell abnormalities. Development 2004; 131: 5185-95.
183. Torcia M, De Chiara G, Nencioni L, et al. Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J Biol Chem 2001; 276: 39027-36.
184. Heese K, Inoue N, Sawada T. NF-kappaB regulates B-cell-derived nerve growth factor expression. Cell Mol Immunol 2006; 3: 63-6.
185. McHeyzer-Williams MG. Immune response decisions at the single cell level. Semin Immunol 1997; 9: 219-27.
186. Okada T, Cyster JG. B cell migration and interactions in the early phase of antibody responses. Curr Opin Immunol 2006; 18: 278-85.
187. Screpanti LD, Meco D, Scarpa S, et al. Neuromodulatory loop mediated by nerve growth factor and Interleukin-6 in thymic stromal cell cultures. Proc Natl Acad Sci USA 1992; 89: 3209-12.
188. Oettgen HC..Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts. Curr Opin Immunol 2000; 12: 618-23.
189. Takatsu K. Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med 1997; 215: 121-33.
190. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17: 701-38.
191. Andrews AL, Holloway JW, Holgate ST, Davies DE. L-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol 2006; 176: 7456-61.
192. Quezada SA, Jarvinen LZ, Lind EF, Noelle RJ. CD40/CD154 interactions at the interface of tolerance and immunity. Annu Rev Immunol 2004; 22: 307-28.
193. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406-10.
194. Edling AE, Nanavati T, Johnson JM, Tuohy VK. Human and murine lymphocyte neurotrophin expression is confined to B cells. J Neurosci Res 2004; 77: 709-17.
195. Brodie C, Gelfand EW. Functional nerve growth factor receptors on human B lymphocytes. Interaction with IL-2. J Immunol 1992; 148: 3492-7.
196. Kerschensteiner M, Gallmeier E, Behrens L, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuro-protective role of inflammation? J Exp Med 1999; 189: 865-70.
197. Lambiase A, Micera A, Sgrulletta R, Bonini S, Bonini S. Nerve growth factor and the immune system: old and new concepts in the cross-talk between immune and resident cells during pathophysiological conditions. Curr Opin Allergy Clin Immunol 2004; 4:425-30.
198. Kronfeld I, Kazimirsky G, Gelfand EW, Brodie C. NGF rescues human B lymphocytes from anti-IgM induced apoptosis by activation of PKCzeta. Eur J Immunol 2002; 32: 136-43.
199. Brelinska R. Thymic epithelial cells in age-dependent involution. Microsc Res Tech 2003; 62: 488-500.
200. Anderson G, Moore NC, Owen JJ, Jenkinson EJ. Cellular interactions in thymocyte development. Annu Rev Immunol 1996; 14: 73-99.
201. Bhandoola A, Sambandam A. From stem cell to T cell: one route or many? Nat Rev Immunol 2006; 6: 117-26.
202. Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 2006; 6: 127-35.
203. Maroder M, Bellavia D, Vacca A, Felli MP, Screpanti I. The thymus at the crossroad of neuroimmune interactions. Ann NY Acad Sci 2000; 917: 741-7.
204. Santambrogio L, Benedetti M, Chao MV, et al. Nerve growth factor production by lymphocytes. J Immunol 1994; 153: 4488-95.
205. Laurenzi MA, Barbany G, Timmusk T, Lindgren JA, Persson H. Expression of mRNA encoding neurotrophins and neurotrophin receptors in rat thymus, spleen tissue and immunocompetent cells. Eur J Biochem 1994; 223: 733-41.
206. Maroder M, Bellavia D, Meco D, et al. Expression of trkB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol 1996; 157: 2864-72.
207. Perez-Pinera P, Garcia-Suarez O, Prieto JG, et al. Thymocyte depletion affects neurotrophin receptor expression in thymic stromal cells. J Anat 2006; 208: 231-8.
208. Garcia-Suarez O, Blanco-Gelaz MA, Lopez ML, et al. Massive lymphocyte apoptosis in the thymus of functionally deficient TrkB mice. J Neuroimmunol 2002; 129: 25-34.
209. Lambiase A, Bracci-Laudiero L, Bonini S, et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 1997; 100: 408-14.
210. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-pbsitive T-cell clones. Proc Natl Acad Sci USA 1993; 90: 10984-8.
211. Garcia-Suarez O, Germans A, Hannestad J, et al. Changes in the expression of the nerve growth factor receptors TrkA and p75LNGR in the rat thymus with ageing and increased nerve growth factor plasma levels. Cell Tissue Res 2000; 301: 225-34.
212. Besser M, Wank R. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 1999; 162: 6303-6.
213. Barouch R, Appel E, Kazimirsky G, Braun A, Renz H, Brodie C. Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes. J Neuroimmunol 2000; 103: 112-21.
214. Hammarberg H, Lidman O, Lundberg C, et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci 2000; 20: 5283-91.
215. Ziemssen T, Kumpfel T, Klinkert WE, Neuhaus O, Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 2002; 125: 2381-91.
216. Jones TB, Basso DM, Sodhi A, et al. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci 2002; 22: 2690-700.
217. Otten U, Gadient RA. Neurotrophins and cytokines - intermediaries between the immune and nervous systems. Int J Dev Neurosci 1995; 13: 147-51.
218. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-84.
219. Lutz M, Krieglstein K, Schmitt S, et al. Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur J Biochem 2004; 271: 920-31.
220. Althini S, Usoskin D, Kylberg A, Kaplan PL, Ebendal T. Blocked MAP kinase activity selectively enhances neurotrophic growth responses. Mol Cell Neurosci 2004; 25:345-54.
221. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1998; 20: 709-26.
222. Hendrix S, Nitsch R. The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol 2007; 184: 100-12.
223. Wardlaw AJ, Brightling CE, Green R, Woltmann G, Bradding P, Pavord ID. New insights into the relationship between airway inflammation and asthma. Clin Sci (Lond) 2002; 103: 201-11.
224. Hoyle GW, Graham RM, Finkelstein JB, Nguyen KP, Gozal D, Friedman M. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol 1998; 18:149-57.
225. Frossard N, Freund V, Advenier C. Nerve growth factor and its receptors in asthma and inflammation. Eur J Pharmacol 2004; 560: 453-65.
226. Nockher WA, Renz H. Neurotrophins and asthma: novel insight into neuroimmune interaction. J Allergy Clin Immunol 2006; 117: 67-71.
227. Bonini S. Lambiase A. Bonini S, et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996; 93: 10955-60.
228. Nassenstein C, Braun A, Nockher WA, Renz H. Neurotrophin effects on eosinophils in allergic inflammation. Curr Allergy Asthma, Rep 2005; 5: 204-11.
229. Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002; 99: 2214-20.
230. Dallos A, Kiss M, Polyanka H, Dobozy A, Kemeny L, Husz S. Effects of tht neuropeptides substance P, calcitonin gene-related peptide, vasoaotive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 2006; 40: 251-63.
231. Ruiz G, Banos JE. The effect of endoneurial nerve growth factor on calcitonin gene-related peptide expression in primary sensory neurons. Brain Res 2005; 1042:44-52.
232. Bracci-Laudiero L, Aloe L, Caroleo MC, et al. Endogenous NGF regulates CGRP expression in human monocytes, and affects HLA-DR and CD86 expression and IL-10 production. Blood 2005; 106: 3507-14.
233. Delafoy L, Gelot A, Ardid D, et al. Interactive involvement of brain derived neurotrophic factor, nerve growth factor, and calcitonin gene related peptide in colonic hypersensitivity in the rat Gut 2006; 55: 940-5.
234. Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 2006; 18: 738-44.
235. Umetsu DT, DeKruyff RH. The regulation of allergy and asthma. Immunol Rev 2006; 212: 238-55.
236. Prussin C, Metcalfe DD. 5. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2006; 117: S450-6.
237. Bonini S, Lambiase A, Lapucci G, et al. Nerve growth factor and asthma. Allergy 57 Suppl 2002; 72: 13-5.
238. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, et al. Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport 1993; 4: 563-5.
239. Dicou E, Masson C, Jabbour W, Nerriere V. Increased frequency of NGF in sera at rheumatoid arthritis and systemic lupus erythematous patients. Neuroreport 1993, 5: 321-4.
240. Aloe L. Tuveri MA. Nerve growth factor and autoimmune rheumatic diseases. Clin Exp Rheumatol 1997; 15: 433-8.
241. Mora C, Navarro JF. Inflammation and diabetic nephropathy. Curr Diab Rep 2006; 6: 463-8.
242. Dobretsov M, Romanovsky D, Stimers JR. Early diabetic neuropathy: Triggers and mechanisms. World J Gastroenterol 2007; 13: 175-91.
243. Hattori A, Iwasaki S, Murase K, et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-gamma in stimulating the production of nerve growth factor in fibroblasts. FEB S Lett 1994; 340: 177-80.
244. Pluss KM, Pfeilschifter J, Muhl H, Huwiler A, Boeckh C, Otten U. Modulatory role of platelet-derived growth factor on cytokine-induced nerve growth factor synthesis in rat glomerular mesangial cells. Biochem J 1995; 312: 707-11.
245. Micera A, Vigneti E, Pickholtz D, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162-7.
246. Sariola H, Saarma M, Sainio K, et al. Dependence of kidney morphogenesis on the expression of nerve growth factor receptor. Science 1991; 254: 571-3.
247. Alpers CE, Hudkins KL, Ferguson M, Johnson RJ, Schatteman GC, Bothwell M. Nerve growth factor receptor expression in fetal, mature, and diseased human kidneys. Lab Invest 1993; 69: 703-13.
248. Pfeilschifter J. Mesangial cells orchestrate inflammation in the renal glomerulus. News Physiol Sci 1994; 9: 271-6.
249. Fogo AB. Progression and potential regression of glomerulosclerosis. Kidney Int 2001; 59: 804-19.
250. Heese K, Beck KF, Behrens MH, et al. Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat renal mesangial cells. Biochem Pharmacol 2003; 65: 293-301.
251. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 1996; 2: 703-7.
252. Scarpini E, Conti G, Chianese L, et al. Induction of p75NGFR in human diabetic neuropathy. J Neurol Sci 1996; 135: 55-62.
253. Farber K, Kettenmann H. Physiology of microglial cells. Brain Res Brain Res Rev 2005; 48: 133-43.
254. Otten U, Marz P, Heese K, Hock C, Kunz D, Rose-John S. Signals regulating neurotrophin expression in glial cells. Prog Brain Res 2001; 132:545-54.
255. Nakajima K, Honda S, Tohyama Y, Imai Y, Kohsaka S, Kurihara T. Neurotrophin secretion from cultured microglia. J Neurosci Res 2001; 65: 322-31.
256. Heese K, Fiebich BL, Bauer J, Otten U. NF-kappaB modulates lipopolysaccharide-induced microglial nerve growth factor expression. Glia 1998; 22: 401-7.
257. Heese K, Hock C, Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998; 70: 699-707.
258. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 2003; 29: 211-30.
259. Licastro F, Candore G, Lio D, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005; 2: 8.
260. Griffin WS. Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006; 83: 470S-4S.
261. Tsai SJ. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects. Med. Hypotheses 2007; 69:145-8.
262. Liotta LA, Kohn E. Anoikis: cancer and the homeless cell. Nature 2004; 430: 973-4.
263. Allen SJ, Dawbarn D. Clinical relevance of the neurotrophins and their receptors. Clin Sci (Lond) 2006, 110: 175-91.
264. Lazarovici P, Marcinkiewicz C, Lelkes PI. Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development. Curr Pharm Des 2006; 12. 2609-22.
265. Rosa R, Garcia AA, Braschi C, et al. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA 2005; 102: 3811-6.
266. Tuszynski MH, Thal L, Pay M, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005; 11: 551-5.
267. Bradbury J. Hope for AD with NGF gene-therapy trial. Lancet Neurol 2005; 4: 335.
268. Scully JL, Otten U. Glucocorticoids, neurotrophins and neurodegeneration. J Steroid Biochem Mol Biol 1995; 52: 391-401.